Nexalin Technology, Inc. (NXL) Stock Price & Analysis

Nexalin Technology, Inc. (NXL) fell 5.34% to USD 4.79 as of September 9, 2026 at 11:21 UTC, according to Nexqual real-time market data.

NXL last closed at USD 4.79; the session ranged USD 4.51–5.02 on volume of 8,275 shares. Market capitalization is —, with a 52-week range of USD 4.51–60 (NCM). Source: Nexqual, September 9, 2026 at 11:21 UTC.

Key Statistics (as of September 9, 2026 at 11:21 UTC)

Technical Analysis (NXL)

Nexqual's technical model rates NXL "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of September 9, 2026 at 11:21 UTC.

From Nexalin Technology, Inc.'s Latest SEC 10-K Filing (filed 2026-03-25)

Key Strengths & Strategy (as disclosed to the SEC)

• We have a proprietary and protected design that stabilizes currents, electromagnetic fields, and various frequencies — referred to collectively as a waveform — particularly our proprietary, 15 milliamp patented waveform.
• We developed an easy-to-administer medical device — referred to as "Generation 1" or "Gen-1" — that utilizes bioelectronic medical technology to treat anxiety, insomnia and depression without the need for drugs or psychotherapy.
• This revenue consists of monthly license fees and payment for the sale of electrodes to clinical providers of our technology.

Partnerships

• The Nexalin regulatory team and the FDA came to a consensus on the Insomnia Clinical research protocols for insomnia assessment scales and timeline end points and patient population size.   In February 2026, the Company entered into a short-term start-up agreement with Lindus Health Limited to support limited clinical trial preparation activities while a broader services agreement is under negotiation.
• The Nexalin virtual clinic will be provided in a proprietary virtual platform currently in the design stage.   In February 2026, the Company entered into a non-binding memorandum of understanding with GreenLight Venture LLC to evaluate a potential strategic collaboration.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 11:21 UTC. This page is informational and not investment advice.